Merck Licenses Bone Drug for Generic Sale
50296
Merck & Company said it had signed a deal for an authorized generic form of its blockbuster osteoporosis drug Fosamax to become available in February.
171143
Barr Pharmaceuticals Inc. reported Friday that the Food and Drug Administration approved its unit&#39;s application to market a generic versions of Bristol-Myers Squibb&#39;s Videx EC delayed-release HIV treatment.
693013
A U.S. judge has granted a request from  Sanofi-Aventis and U.S. partner Bristol-Myers Squibb Co.   to block the sale in the United States of a generic  form of its top selling blood-thinner Plavix, giving a boost to  shares in the French drugmaker on Friday.
310914
NEW YORK, December 8  - Merck &amp; Co (MRK.NYS) has guided to lower-than-expected 2005 earnings due to the withdrawal of its blockbuster arthritis drug, Vioxx, and increased generic competition for its cholesterol drug, Zocor.
700315
German drugmaker Merck KGaA   unveiled a surprise 16.6-billion-Swiss franc ($13.3  billion) deal to buy Swiss biotech firm Serono on Thursday,  creating a new force in European pharmaceuticals.
557
TRENTON, N.J. -- A federal court invalidated the patent yesterday for Merck &amp; Co.'s second-largest-selling drug, the blockbuster osteoporosis treatment Fosamax, in a decision that offers millions of patients hope for a cheaper version sooner, but darkens the company's already clouded outlook.
125021
Merck & Co. MRK.N on Friday said  U.S. regulators have decided not to approve the company's  experimental arthritis drug, the successor to its recalled  Vioxx pill, until more safety and effectiveness data are  obtained.
78500
India's Ranbaxy Laboratories Ltd. has received the U.S. Food and Drug Administration's approval for clarithromycin, a generic form of Abbott Laboratories Inc.'s antibiotic Biaxin, the FDA said on Saturday.
125992
Merck has obtained rights to license an experimental anti-obesity drug that is based on a hormone the body uses to signal that it has eaten enough.
502454
The deal, which must be approved by regulators, will make the German group the number one generics company in Scandinavia, a growing market worth about 600m last year, according to Merck.
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.
389447
Roche Holding AG and GlaxoSmithKline  said on Wednesday they asked U.S. regulators to approve an  intravenous form of their osteoporosis drug that could be  administered far less frequently.
81672
The pharmaceutical giant is selling its pain relievers and other consumer products.
384652
Drug maker Merck & Co. Inc. said on Friday it acted "responsibly and appropriately" in developing and marketing recently recalled arthritis drug Vioxx.
525567
Drug maker Merck & Co. Inc.  urged U.S. advisers on Thursday to approve the first over-the-counter sales of a cholesterol-lowering pill, but regulators questioned if consumers would use it properly.
382580
Genzyme Corp. of Cambridge, Mass., agreed Thursday to buy back the sales and marketing rights for Synvisc, a pain treatment for people suffering from osteoarthritis of the knee, from Wyeth Pharmaceuticals of Collegeville, Pa.
626150
Merck & Co Inc. won U.S. approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.